← FDA Drug Approvals (Drugs@FDA)
RENOGRAFIN-76
NDA · New Drug Application · Sponsor: BRACCO · Approved 1955-08-02
Drug application
- FDA Application #
NDA010040- Application type
- New Drug Application
- Brand name
- RENOGRAFIN-76
- Generic name
- DIATRIZOATE MEGLUMINE
- Active ingredients
- DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- BRACCO
- Manufacturer
- BRACCO DIAGNOSTICS INC
- First approval
- 1955-08-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown